市場調査レポート

商品コード

1623742

臨床試験材料・消耗品の市場規模、シェア、成長分析、サービス別、フェーズ別、タイプ別、治療領域別、地域別 - 産業予測、2025～2032年

Clinical Trial Materials And Supplies Market Size, Share, Growth Analysis, By Service (Logistics & Distribution, Storage & Retention), By Phase (Phase I, Phase II), By Type, By Therapeutic Area, By Region - Industry Forecast 2025-2032

出版日: 2024年12月26日
発行: SkyQuest
ページ情報: 英文 260 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 763,518円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 893,172円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,022,826円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
目次

概要

サンプル依頼リストに入れる

臨床試験材料・消耗品の世界市場規模は、2023年に35億米ドルと評価され、2024年の38億4,000万米ドルから2032年には81億2,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは9.8％で成長する見通しです。

臨床試験用品の管理は、特に薬剤検出コストの上昇に伴い、在庫切れや過剰生産などの問題を回避するために極めて重要です。効果的なサプライチェーン管理は臨床研究において不可欠であり、インフラの制限や厳しい規制に対処する必要があります。主な市場促進要因としては、臨床試験の拡大と複雑化が挙げられます。臨床試験用品には、輸液ポンプ、ネブライザー、注射針など様々な器具が含まれ、心臓血管、神経、腫瘍、肺の各分野における疾患の評価と治療に極めて重要です。医薬品開発・製造業者による消耗品のアウトソーシングは増加しており、治験実施施設へのタイムリーなデリバリーが確保されています。さらに、技術の進歩、ソリューション・プロバイダー間の戦略的成長、特許失効の増加が臨床試験材料の需要に拍車をかけ、市場の堅調な成長に寄与しています。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
収益の前年比比較（2022-2024）

主要企業プロファイル

Lonza Group
Catalent, Inc.
Piramal Pharma Solutions
Almac Group
Parexel International
Eurofins Scientific
Marken（A Subsidiary of UPS）
Thermo Fisher Scientific, Inc.
Sharp Services, LLC
PCI Pharma Services
Nuvisan
Celerion
WuXi AppTec
Recipharm AB
Tunnell Consulting
Aesica Pharmaceuticals
Boehringer Ingelheim
Kendle International（Now a part of INC Research）
Syneos Health
Vetter Pharma

結論と推奨事項

Product Code: SQMIG35B2074

Global Clinical Trial Materials And Supplies Market size was valued at USD 3.5 billion in 2023 and is poised to grow from USD 3.84 billion in 2024 to USD 8.12 billion by 2032, growing at a CAGR of 9.8% during the forecast period (2025-2032).

The management of clinical trial supplies is critical to avert issues such as inventory expiration and overproduction, especially as drug detection costs rise. Effective supply chain management is essential in clinical research, addressing infrastructure limitations and stringent regulations. Key market drivers include the expansion and growing complexity of clinical trials. Clinical trial supplies encompass various instruments like infusion pumps, nebulizers, and syringe needles, pivotal for evaluating and treating diseases across cardiovascular, neurological, oncological, and pulmonary fields. Outsourcing of supplies by drug developers and manufacturers is increasing, ensuring timely delivery to investigator sites. Additionally, technological advancements, strategic growth among solution providers, and a rise in patent expirations have fueled demand for clinical trial materials, contributing to robust market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Clinical Trial Materials And Supplies market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Clinical Trial Materials And Supplies Market Segmental Analysis

Global Clinical Trial Materials And Supplies Market is segmented by service, phase, type, therapeutic area, end user and region. Based on service, the market is segmented into logistics & distribution, storage & retention, packaging, labelling & blinding, manufacturing, comparator sourcing and other services. Based on phase, the market is segmented into Phase I, Phase II, Phase III, Phase IV, BA/BE Studies. Based on type, the market is segmented into small-molecules, biologic drugs and medical devices. Based on therapeutic area, the market is segmented into oncology, infectious diseases, neurology, metabolic disorders, immunology, cardiology, genetic diseases and other therapeutic areas. Based on end user, the market is segmented into pharmaceutical and biotechnology companies, contract research organisations (CRO's) and medical device companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Clinical Trial Materials And Supplies Market

The Global Clinical Trial Materials and Supplies market is significantly driven by the increasing participation of patients in clinical trials within emerging economies such as China, India, and South Korea. The lower costs associated with conducting clinical trials in these nations-28% cheaper before tax incentives and a remarkable 60% less expensive after tax incentives compared to the United States-have attracted pharmaceutical companies seeking to optimize their research expenditures. This trend has also led to a shift in clinical trial locations, particularly for rare diseases. Furthermore, advancements in technology and data analytics contribute to improved decision-making in clinical trials, prompting the pharma and biotech sectors to invest in outsourcing innovative solutions that enhance trial processes and supply chains in these developing markets.

Restraints in the Global Clinical Trial Materials And Supplies Market

The Global Clinical Trial Materials and Supplies market faces considerable restraints primarily due to the high attrition rates of drug candidates during development, which lead to immense research and development costs. The complexities associated with R&D for rare diseases often require specialized personnel to conduct clinical trials, further complicating the process. For instance, only 7 out of 100 cancer drugs that reach clinical trials ultimately gain regulatory approval, with most drug candidates failing before this stage. Additionally, the entire journey from drug discovery to FDA approval can span 10-15 years and incur costs around USD 2.6 billion, with less than 12% of candidates reaching Phase clinical trials successfully, posing significant challenges to market expansion.

Market Trends of the Global Clinical Trial Materials And Supplies Market

The Global Clinical Trial Materials and Supplies market is witnessing a notable trend towards the increased utilization of biologics and temperature-sensitive medications, with approximately 35% of late-phase pharmaceutical drugs classified as biologics, alongside 38% being temperature-sensitive. This shift is largely attributed to the advantages biologics offer, including fewer side effects compared to traditional pharmaceuticals. With the expectation that the prevalence of biologics will continue to rise, there is a corresponding surge in demand for advanced cold chain logistics and storage solutions to ensure the efficacy and safety of these sensitive materials during clinical trials, thereby shaping the future landscape of the market.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Supply Chain Analysis
Technology Analysis
Regulatory Analysis

Global Clinical Trial Materials And Supplies Market Size by Service & CAGR (2025-2032)

Market Overview
Logistics & Distribution
Storage & Retention
Packaging, Labelling & Blinding
Manufacturing
Comparator Sourcing
Other Services

Global Clinical Trial Materials And Supplies Market Size by Phase & CAGR (2025-2032)

Market Overview
Phase I
Phase II
Phase III
Phase IV
BA/BE Studies

Global Clinical Trial Materials And Supplies Market Size by Type & CAGR (2025-2032)

Market Overview
Small-Molecules
Biologic Drugs
Medical Devices

Global Clinical Trial Materials And Supplies Market Size by Therapeutic Area & CAGR (2025-2032)

Market Overview
Oncology
Infectious Diseases
Neurology
Metabolic Disorders
Immunology
Cardiology
Genetic Diseases
Other Therapeutic Areas

Global Clinical Trial Materials And Supplies Market Size by End User & CAGR (2025-2032)

Market Overview
Pharmaceutical And Biotechnology Companies
Contract Research Organisations (CRO's)
Medical Device Companies

Global Clinical Trial Materials And Supplies Market Size & CAGR (2025-2032)

North America (Service, Phase, Type, Therapeutic Area, End User)
- US
- Canada
Europe (Service, Phase, Type, Therapeutic Area, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Service, Phase, Type, Therapeutic Area, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Service, Phase, Type, Therapeutic Area, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Service, Phase, Type, Therapeutic Area, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Lonza Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Catalent, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Piramal Pharma Solutions
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Almac Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Parexel International
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Marken (A Subsidiary of UPS)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sharp Services, LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PCI Pharma Services
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nuvisan
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Celerion
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WuXi AppTec
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Recipharm AB
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tunnell Consulting
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aesica Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kendle International (Now a part of INC Research)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Syneos Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vetter Pharma
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

臨床試験材料・消耗品の市場規模、シェア、成長分析、サービス別、フェーズ別、タイプ別、治療領域別、地域別 - 産業予測、2025～2032年

Clinical Trial Materials And Supplies Market Size, Share, Growth Analysis, By Service (Logistics & Distribution, Storage & Retention), By Phase (Phase I, Phase II), By Type, By Therapeutic Area, By Region - Industry Forecast 2025-2032

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

臨床試験材料・消耗品市場規模：サービス別

臨床試験材料・消耗品市場規模：フェーズ別

臨床試験材料・消耗品市場規模：タイプ別

臨床試験材料・消耗品市場規模：治療領域別

臨床試験材料・消耗品市場規模：エンドユーザー別

臨床試験材料・消耗品市場規模